Financial results - IMMUNOEYE SRL

Financial Summary - Immunoeye Srl
Unique identification code: 30155007
Registration number: J2012000129146
Nace: 8622
Sales - Ron
948.229
Net Profit - Ron
200.572
Employees
12
Open Account
Company Immunoeye Srl with Fiscal Code 30155007 recorded a turnover of 2024 of 948.229, with a net profit of 200.572 and having an average number of employees of 12. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Immunoeye Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 21.576 88.629 144.545 204.705 265.367 370.251 815.137 854.177 830.254 948.229
Total Income - EUR 27.791 95.467 148.933 208.125 277.627 380.091 879.145 903.426 894.379 1.019.367
Total Expenses - EUR 19.252 51.645 82.434 102.701 131.059 189.553 423.539 441.180 701.775 798.655
Gross Profit/Loss - EUR 8.540 43.822 66.499 105.423 146.567 190.537 455.606 462.246 192.604 220.712
Net Profit/Loss - EUR 7.708 42.935 65.053 103.471 144.109 188.179 449.976 456.645 189.770 200.572
Employees 2 5 6 6 7 7 12 12 11 12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 14.9%, from 830.254 euro in the year 2023, to 948.229 euro in 2024. The Net Profit increased by 11.863 euro, from 189.770 euro in 2023, to 200.572 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Immunoeye Srl

Rating financiar

Financial Rating -
IMMUNOEYE SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Immunoeye Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Immunoeye Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Immunoeye Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Immunoeye Srl - CUI 30155007

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 12.770 52.199 59.948 47.612 323.548 980.462 933.022 864.112 986.423 927.557
Current Assets 48.404 25.308 50.269 655.913 509.241 191.314 215.198 688.555 480.791 594.047
Inventories 0 1.765 1.520 2.773 0 9.283 29.580 2.385 7.951 0
Receivables 49 4.319 6.722 501.222 384.149 154.840 22.754 363.964 29.403 8.380
Cash 48.355 19.224 42.028 65.961 41.160 27.191 61.318 119.209 200.786 384.633
Shareholders Funds 54.475 42.998 95.846 197.558 337.841 517.439 711.634 1.086.813 908.910 1.098.284
Social Capital 45 45 88 86 84 83 81 628.612 626.706 623.203
Debts 6.699 34.509 4.868 3.794 4.090 178.618 16.125 84.751 54.416 -12.763
Income in Advance 0 14.077 9.504 502.173 490.857 475.719 420.461 381.103 506.499 452.203
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 594.047 euro in 2024 which includes Inventories of 0 euro, Receivables of 8.380 euro and cash availability of 384.633 euro.
The company's Equity was valued at 1.098.284 euro, while total Liabilities amounted to -12.763 euro. Equity increased by 194.453 euro, from 908.910 euro in 2023, to 1.098.284 in 2024. The Debt Ratio was -0.8% in the year 2024.

Risk Reports Prices

Reviews - Immunoeye Srl

Comments - Immunoeye Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.